Beta Drugs Limited — Others, 07-11-2024: Corrigendum

Beta Drugs Limited has issued a second corrigendum to its Extraordinary General Meeting (EGM) Notice, scheduled for November 12, 2024. This update modifies points related to funding purposes and identifies proposed allottees for a preferential issue of equity shares and compulsory convertible debentures. The details include intended use of funds, which totals ₹117 crore for various corporate goals. The corrigendum reinforces that all other items in the original EGM Notice remain unchanged.